Physician profile
Troy C Williams
NPI 1093929630
$2,101.08
in general payments reported to CMS, 2019-2025
19 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $264 · 2021: $222 · 2022: $286 · 2023: $415 · 2024: $352 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $595.31 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Aspira Women'S Health INC | $263.30 | 2019-2024 | Ova1 |
| Therapeuticsmd, INC. | $211.57 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $184.79 | 2022-2025 | |
| Novo Nordisk INC | $173.50 | 2023-2025 | Wegovy, Saxenda |
| Pfizer INC. | $97.89 | 2022-2024 | |
| Allergan, INC. | $84.44 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $82.54 | 2019-2020 | |
| Becton, Dickinson and Company | $66.58 | 2023-2024 | Bd Onclarity |
| Shield Therapeutics INC | $66.08 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $49.51 | 2025 | Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $47.44 | 2024-2025 | Myfembree |
| Kowa Pharmaceuticals America, INC. | $39.02 | 2023 | Seglentis |
| Exact Sciences Corporation | $34.64 | 2024 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $32.33 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $30.21 | 2025 | Endosee |
| Vertical Pharmaceuticals, LLC | $15.38 | 2019 | |
| Evofem Biosciences, INC. | $13.86 | 2022 | |
| Avion Pharmaceuticals | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.